Stay updated on Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Sign up to get notified when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.

Latest updates to the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.3 was added; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedNew revision label v3.3.2 appears in the Record History, replacing the previous v3.2.0. This seems to be a routine site update and does not alter study data or core page content.SummaryDifference0.1%

- Check42 days agoChange DetectedThe funding-status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check56 days agoChange DetectedThe new screenshot adds an updated version entry in the Record History showing a change to the Study Status and related fields since the last version. This reflects progression of the trial's record over time.SummaryDifference0.1%

- Check84 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference12%

- Check92 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric MRD+ CD22+ ALL: Inotuzumab Clinical Trial page.